These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32925095)

  • 21. Treatment of Nonmotor Symptoms in Parkinson's Disease.
    Sauerbier A; Cova I; Rosa-Grilo M; Taddei RN; Mischley LK; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():361-379. PubMed ID: 28554415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease.
    Cubo E; Martínez-Martín P; González-Bernal J; Casas E; Arnaiz S; Miranda J; Gámez P; Santos-García D;
    J Parkinsons Dis; 2020; 10(4):1611-1620. PubMed ID: 32741839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-motor symptoms in Parkinson's disease.
    Park A; Stacy M
    J Neurol; 2009 Aug; 256 Suppl 3():293-8. PubMed ID: 19711119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-motor symptoms of Parkinson's disease: diagnosis and management.
    Salawu FK; Danburam A; Olokoba AB
    Niger J Med; 2010; 19(2):126-31. PubMed ID: 20642073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic Symptoms Correlate with Non-Autonomic Non-Motor Symptoms and Sleep Problems in Patients with Parkinson's Disease.
    Matsubara T; Suzuki K; Fujita H; Watanabe Y; Sakuramoto H; Matsubara M; Hirata K
    Eur Neurol; 2018; 80(3-4):193-199. PubMed ID: 30572329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease.
    Liu R; Umbach DM; Peddada SD; Xu Z; Tröster AI; Huang X; Chen H
    Neurology; 2015 May; 84(21):2107-15. PubMed ID: 25925983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease.
    Gaig C; Vilas D; Infante J; Sierra M; García-Gorostiaga I; Buongiorno M; Ezquerra M; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    PLoS One; 2014; 9(10):e108982. PubMed ID: 25330404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latent Cognitive Phenotypes in De Novo Parkinson's Disease: A Person-Centered Approach.
    LaBelle DR; Walsh RR; Banks SJ
    J Int Neuropsychol Soc; 2017 Aug; 23(7):551-563. PubMed ID: 28651678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients.
    Saleem S; Anwar A
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):135. PubMed ID: 31168642
    [No Abstract]   [Full Text] [Related]  

  • 30. The nonmotor features of Parkinson's disease: pathophysiology and management advances.
    Reichmann H; Brandt MD; Klingelhoefer L
    Curr Opin Neurol; 2016 Aug; 29(4):467-73. PubMed ID: 27262147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.
    Hall JM; Shine JM; Walton CC; Gilat M; Kamsma YP; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):604-7. PubMed ID: 24679901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-motor symptoms in Parkinson's disease: An explorative network study.
    Engels G; Douw L; Kerst Y; Weinstein H; Scherder E; Vlaar A
    Parkinsonism Relat Disord; 2019 Sep; 66():237-240. PubMed ID: 31434631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premotor and nonmotor features of Parkinson's disease.
    Goldman JG; Postuma R
    Curr Opin Neurol; 2014 Aug; 27(4):434-41. PubMed ID: 24978368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.
    Papadimitriou D; Antonelou R; Miligkos M; Maniati M; Papagiannakis N; Bostantjopoulou S; Leonardos A; Koros C; Simitsi A; Papageorgiou SG; Kapaki E; Alcalay RN; Papadimitriou A; Athanassiadou A; Stamelou M; Stefanis L
    Mov Disord; 2016 Aug; 31(8):1226-30. PubMed ID: 27028329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson's disease.
    Tong Q; Xu Q; Xia Q; Yuan Y; Zhang L; Sun H; Shan H; Zhang K
    J Neural Transm (Vienna); 2015 Mar; 122(3):411-7. PubMed ID: 25059457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of autonomic dysfunction in idiopathic Parkinson's disease.
    Korchounov A; Kessler KR; Yakhno NN; Damulin IV; Schipper HI
    J Neurol; 2005 Dec; 252(12):1530-6. PubMed ID: 16362830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.
    Jang W; Park J; Shin KJ; Kim JS; Kim JS; Youn J; Cho JW; Oh E; Ahn JY; Oh KW; Kim HT
    J Neurol Sci; 2014 Feb; 337(1-2):47-54. PubMed ID: 24289887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control Study.
    Schroeder LA; Rufra O; Sauvageot N; Fays F; Pieri V; Diederich NJ
    Sleep; 2016 Dec; 39(12):2133-2139. PubMed ID: 27748239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis?
    Postuma RB
    Int Rev Neurobiol; 2017; 133():519-539. PubMed ID: 28802931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson's disease.
    Qamar MA; Tall P; van Wamelen D; Wan YM; Rukavina K; Fieldwalker A; Matthew D; Leta V; Bannister K; Chaudhuri KR
    Int Rev Neurobiol; 2024; 174():1-58. PubMed ID: 38341227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.